Kennedy Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Kennedy Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.74M	Sell	13,440 -633	-4%	-$304K	0.12%	275
2026 Q1	$6.92M	Buy	14,073 +278	+2%	+$151K	0.15%	233
2025 Q4	$7.99M	Sell	13,795 -48	-0.3%	-$27.1K	0.17%	199
2025 Q3	$6.71M	Sell	13,843 -10,052	-42%	-$4.68M	0.15%	241
2025 Q2	$9.69M	Sell	23,895 -3,935	-14%	-$1.65M	0.23%	146
2025 Q1	$13.8M	Sell	27,830 -6,542	-19%	-$3.54M	0.33%	85
2024 Q4	$17.9M	Buy	34,372 +4,084	+13%	+$2.25M	0.4%	45
2024 Q3	$18.7M	Buy	30,288 +4,671	+18%	+$2.77M	0.41%	44
2024 Q2	$14.2M	Buy	25,617 +5,561	+28%	+$3.19M	0.3%	89
2024 Q1	$11.7M	Buy	+20,056	New	+$11.3M	0.24%	136

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Kennedy Capital Management's TMO Position: Q2 2026 in Review

Kennedy Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 4.5% in Q2 2026, selling an estimated $304K and leaving 13,440 shares worth $6.74M. The position accounts for 0.12% of the portfolio, ranked #275.

Kennedy Capital Management first reported a position in TMO in Q1 2024 and has held it in 10 quarters since. The position peaked at $18.7M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Kennedy Capital Management held 13,440 shares of Thermo Fisher Scientific worth $6.74M as of Q2 2026.
Kennedy Capital Management sold 633 Thermo Fisher Scientific shares in Q2 2026, an estimated $304K.
Thermo Fisher Scientific made up 0.12% of Kennedy Capital Management's portfolio in Q2 2026, its #275 holding.
Kennedy Capital Management first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 10 quarters since.
Kennedy Capital Management's Thermo Fisher Scientific position peaked at $18.7M in Q3 2024.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.